Mankind Pharma partners with Innovent to aid cancer treatment in India

Domestic pharma maker Mankind pharma announced their partnership with Innovent Biologics to exclusively license and sell sintilimab, an advanced PD-1 immunotherapy, in the Indian market. 🔹According to The national cancer registry programme cancer has become a major health concern in India, with its burden projected to reach 29.8 million DALYs by 2025. 🔹Sintilimab, marketed as … Read more